Nonalcoholic fatty liver disease and accelerated loss of skeletal muscle mass: A longitudinal cohort study.

Dong Hyun SinnDanbee KangMira KangEliseo GuallarYun Soo HongKyung-Hyun LeeJiyeon ParkJuhee ChoGeum-Youn Gwak

Published in: Hepatology (Baltimore, Md.) (2022)

Participants with NAFLD were at increased risk of sarcopenia, indicated by faster loss of skeletal muscle mass. Patients with NAFLD may need screening and early intervention to mitigate skeletal muscle mass loss.

Keyphrases

skeletal muscle
randomized controlled trial
insulin resistance
type diabetes
metabolic syndrome